Promoting Palliative Care for People With Heart Failure

This study is testing a new tool called a Clinical Decision Support Tool. This tool is designed to help healthcare providers decide when to refer people with heart failure to palliative care (specialized medical care for people with serious illnesses). The tool will provide information about a patient's likely survival and other helpful guidance. The study aims to see if this tool can improve the care you receive if you have heart failure, making sure your care matches your goals. This study is for healthcare providers who work in hospitals and care for people with heart failure. We don't know the current recruitment status, but the study plans to include 2260 participants. Success in this study will be measured by how easy the tool is to use, how acceptable it is to providers, and how appropriate they find it, all measured over about 15 months.

Study design
This is an interventional study, meaning it tests a specific intervention. It plans to enroll 2260 participants, though the specific study phase is not mentioned.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main study measures will be taken for up to 15 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06933875

Promoting Palliative Care for People With Heart Failure

Recruiting
NAAges 18+InterventionalSupportive care
Yale University
~2,260 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Clinical Decision Support Tool

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean System Usability Scale score
Measured over up to 15 months
+3 more outcomes measured
Heart Failure
Palliative Care

NCT06933875

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Yale New Haven Hospital Saint Raphael

    New Haven, Connecticutno site contact published

    Recruiting

  • Yale New Haven Hospital York Street

    New Haven, Connecticutno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Shelli Feder, PhD · PRINCIPAL_INVESTIGATOR · Yale University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
Has ordering privileges
Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
Anticipate employment at one of the two study sites for the 15-month trial period.
Palliative care team member
Hospital administrator/quality and safety personnel
Age 18 years of age or older
N-terminal pro-B-type natriuretic peptide values of \>500 pg/ml
Received intravenous diuretics within 24 hours of admission.

Exclusion

Pregnant at the time of admission.
  • Mean System Usability Scale scoreup to 15 months

    System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability

  • Mean Acceptability of Intervention Measure scoreup to 15 months

    Acceptability of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher acceptability.

  • Mean Appropriateness of Intervention Measure scoreup to 15 months

    Appropriateness of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher appropriateness.

  • Mean Feasibility of Intervention Measure scoreup to 15 months

    Feasibility of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher feasibility.